PortfoliosLab logo

Aligos Therapeutics, Inc. (ALGS)

Equity · Currency in USD · Last updated Nov 28, 2022

Company Info

ISINUS01626L1052
CUSIP01626L105
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$1.04
Year Range$0.89 - $15.32
EMA (50)$1.08
EMA (200)$3.07
Average Volume$75.55K
Market Capitalization$40.67M

ALGSShare Price Chart


Loading data...

ALGSPerformance

The chart shows the growth of $10,000 invested in Aligos Therapeutics, Inc. in Oct 2020 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $660 for a total return of roughly -93.40%. All prices are adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%20.00%JuneJulyAugustSeptemberOctoberNovember
-23.26%
-2.57%
ALGS (Aligos Therapeutics, Inc.)
Benchmark (^GSPC)

ALGSCompare to other instruments

Search for stocks, ETFs, and funds to compare with ALGS

ALGSReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-1.98%4.33%
6M-16.81%-0.78%
YTD-91.66%-15.53%
1Y-93.93%-14.36%
5Y-72.40%7.10%
10Y-72.40%7.10%

ALGSMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-73.13%-24.14%-11.16%-45.12%9.32%-6.20%2.48%0.81%-12.00%-4.55%-5.71%
20211.88%2.02%-20.88%13.10%8.40%-26.88%-28.53%17.02%-9.03%2.71%-3.83%-22.52%
2020-0.40%25.23%47.78%

ALGSSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aligos Therapeutics, Inc. Sharpe ratio is -0.95. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.200.00JuneJulyAugustSeptemberOctoberNovember
-0.95
-0.60
ALGS (Aligos Therapeutics, Inc.)
Benchmark (^GSPC)

ALGSDividend History


Aligos Therapeutics, Inc. doesn't pay dividends

ALGSDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovember
-97.17%
-16.06%
ALGS (Aligos Therapeutics, Inc.)
Benchmark (^GSPC)

ALGSWorst Drawdowns

The table below shows the maximum drawdowns of the Aligos Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aligos Therapeutics, Inc. is 97.44%, recorded on Nov 9, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.44%Jan 21, 2021456Nov 9, 2022
-22.62%Nov 17, 202010Dec 1, 20208Dec 11, 202018
-20.62%Dec 24, 20204Dec 30, 20209Jan 13, 202113
-12%Oct 16, 20203Oct 20, 20202Oct 22, 20205
-10.79%Nov 10, 20201Nov 10, 20203Nov 13, 20204
-8.82%Jan 15, 20212Jan 19, 20211Jan 20, 20213
-5.85%Nov 5, 20201Nov 5, 20202Nov 9, 20203
-4.65%Oct 28, 20202Oct 29, 20204Nov 4, 20206
-3.82%Dec 15, 20201Dec 15, 20201Dec 16, 20202
-1.99%Oct 26, 20201Oct 26, 20201Oct 27, 20202

ALGSVolatility Chart

Current Aligos Therapeutics, Inc. volatility is 89.04%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%JuneJulyAugustSeptemberOctoberNovember
89.04%
12.31%
ALGS (Aligos Therapeutics, Inc.)
Benchmark (^GSPC)